findmyKOL
Clinical trialNCT06803589RecruitingEarly phase 1Interventional

Growth Hormone for the Treatment of Gastroparesis

SponsorMayo ClinicEnrollment10Gastroparesis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic

    Phoenix, Arizona, United States

    Recruiting
  • Mayo Clinic in Arizona

    Scottsdale, Arizona, United States

    Tisha Najet Lunsford
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Oct 2024
Primary completion
31 Oct 2027
Completion
31 Dec 2027
Last update posted
16 Apr 2026
Registered enrollment
10
Registry id
NCT06803589

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.